The protein complex mTORC1 is a central regulator of cell metabolism. In the active state, it stimulates anabolic processes and increases the production and storage of proteins and lipids.
Researchers from the German Leibniz Institute for Age Research in Jena and the Dutch Ageing Institute ERIBA in Groningen discovered a mechanism how mTORC1 regulates metabolism: It controls the expression of a specific variant of the transcriptional regulator C/EBPβ.
Elimination of this variant in mice results in a healthy metabolism, leanness and improved insulin sensitivity. The study may provide a basis for novel strategies for the treatment of metabolic diseases such as obesity and type II diabetes.
The mTORC1 (mammalian target of rapamycin complex 1) is a central regulator of cell metabolism and its activity is regulated by nutrient availability and growth signals. If activated, it stimulates anabolic metabolism and enhanced production of proteins and lipids.
The resulting increase in biomass is a prerequisite for tissue growth. Hyper-activation of mTORC1 by overfeeding may result in obesity and is believed to promote metabolic disorders such as type II diabetes. In contrast, a calorie restricted diet decreases mTORC1 activity. This improves metabolic health and increases life span in many species up to mammals.
Many researchers have focused on mTORC1 function during the past years because of its crucial role in metabolism. However, little is known about factors that are specifically controlled by mTORC1 and that are responsible for the regulation of genes that are important for metabolic adjustments.
Now, researchers from Leibniz Institute for Age Research – Fritz Lipmann Institute (FLI) in Jena, Germany, and European Research Institute for the Biology of Ageing (ERIBA) in Groningen, Netherlands, found a mechanism through which mTORC1 regulates metabolic processes. The research results were published in renowned journal EMBO Reports.
Switching on and off metabolic gene transcription.
“Researchers already know a lot about how mTORC1 is activated by nutrient supply. But little is known about the downstream factors that regulate metabolic genes and thereby determine the metabolic state of an organism”, Prof. Dr. Cornelis Calkhoven (ERIBA), former group leader at FLI, explains.
A main function of mTORC1 is the stimulation of mRNA translation, which is the crucial and final process in gene expression that results in production of the biologically active proteins. “We now found a factor – C/EBPβ – which is controlled by mTORC1”, Calkhoven continues. C/EBPβ is a gene regulator that controls various metabolic genes. Within cells, there exist two kinds of C/EBPβ: the long variant is a gene activator, whereas the short variant suppresses genes.
“Our data show that mTORC1 specifically promotes the formation of the short variant of C/EBPβ”, Dr. Christine Müller (ERIBA), former researcher at FLI, states. The researchers used a mouse model in which a mutation in the C/EBPβ gene prevents the production of the short C/EBPβ variant even if mTORC1 is activated. “Intriguingly, our data show that mice with this mutation display an improved metabolic phenotype, including reduced fat metabolism and fat accumulation, and improved insulin sensitivity and glucose tolerance”, Dr. Laura Zidek, Postdoc at FLI, emphasizes the findings.
“The healthy metabolic phenotype we observed in our mouse model is similar to what is found under calorie restriction”, Calkhoven explains. Interestingly, these positive effects can be achieved without reduction in food intake: the mice are lean but sated.
“Our study shows that the mechanism regulating the formation of C/EBPβ variants is an important molecular switch in the metabolic pathway controlled by mTORC1. Thus, pharmacological targeting of C/EBPβ isoform expression may provide a promising strategy for the treatment of metabolic diseases such as obesity and type II diabetes thereby extending health span.
Zidek LM, Ackermann T, Hartleben G, Eichwald S, Kortman G, Kiehntopf M, Leutz A, Sonenberg N, Wang ZQ, von Maltzahn J, Müller C, Calkhoven CF. Deficiency in mTORC1-controlled 1 C/EBPβ -mRNA translation improves metabolic health in mice. EMBO Rep. 2015. pii: e201439837. DOI 10.15252/embr.201439837.
Dr. Evelyn Kästner
Leibniz Institute for Age Research – Fritz Lipmann Institute (FLI)
Beutenbergstr. 11, 07745 Jena, Germany
Phone: +49 (0)3641-656373, Fax: +49 (0)3641-656351, E-Mail: email@example.com
The Leibniz Institute for Age Research – Fritz Lipmann Institute (FLI) is the first German research organization dedicated to biomedical aging research since 2004. More than 330 members from over 30 nations explore the molecular mechanisms underlying aging processes and age-associated diseases. For more information, please visit http://www.fli-leibniz.de.
Dutch European Research Institute for the Biology of Ageing (ERIBA) was founded by the University Medical Center Groningen (UMCG) in 2013. ERIBA is an internationally orientated research institute focusing on fundamental biological problems related to aging and age-associated diseases. See http://www.umcg.nl/EN/Research/ERIBA for more information.
The Leibniz Association connects 89 independent research institutions that range in focus from the natural, engineering and environmental sciences via economics, spatial and social sciences to the humanities. Leibniz Institutes address issues of social, economic and ecological relevance. They conduct knowledge-driven and applied basic research, maintain scientific infrastructure and provide research-based services. The Leibniz Association identifies focus areas for knowledge transfer to policy-makers, academia, business and the public. Leibniz Institutes collaborate intensively with universities – in the form of “WissenschaftsCampi” (thematic partnerships between university and non-university research institutes), for example – as well as with industry and other partners at home and abroad. They are subject to an independent evaluation procedure that is unparalleled in its transparency. Due to the institutes’ importance for the country as a whole, they are funded jointly by the Federation and the Länder, employing some 18,100 individuals, including 9,200 researchers. The entire budget of all the institutes is approximately 1.64 billion EUR. See http://www.leibniz-association.eu for more information.
http://www.fli-leibniz.de - Website Leibniz Institute for Age Research - Fritz Lipmann Institute (FLI) Jena
Dr. Kerstin Wagner | idw - Informationsdienst Wissenschaft
New photocatalyst speeds up the conversion of carbon dioxide into chemical resources
29.05.2017 | DGIST (Daegu Gyeongbuk Institute of Science and Technology)
Copper hydroxide nanoparticles provide protection against toxic oxygen radicals in cigarette smoke
29.05.2017 | Johannes Gutenberg-Universität Mainz
The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.
The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
29.05.2017 | Earth Sciences
29.05.2017 | Life Sciences
29.05.2017 | Physics and Astronomy